Nodular Lymphocyte Predominance Hodgkin's Disease: Long-Term Observation Reveals a Continuous Pattern of Recurrence

References

• Lukes R.J., Butler J.J., Hicks E.B. Natural history of Hodgkin's disease as related to its pathologic picture. Cancer 1966; 19: 317–324
   Web of Science ®Google Scholar
• Colby T.V., Hoppe R.T., Warnke R.A. Hodgkin's disease: A clinicopathologic study of 659 cases. Cancer 1981; 49: 1848–58
   Web of Science ®Google Scholar
• Mauch P.M., Kalish L.A., Kadin M.C., Coleman C.N., Osteen R., Hellman S. Patterns of presentation of Hodgkin's disease: implications for etiology and pathogenesis. Cancer 1993; 71: 2062–2071
   PubMed Web of Science ®Google Scholar
• Pinkus G., Said J. Hodgkin's Disease, Lymphocyte Predominance type. Further evidence for a B-cell derivation: L&H variants of Reed-Stemberg cells express L26, a pan B-cell marker. American Journal of Pathology 1988; 133: 211–17
   PubMed Web of Science ®Google Scholar
• Poppema S. Lymphocyte-Predominance Hodgkin's Disease. Seminars Diagnostic Pathology 1992; 9: 257–64
   PubMed Web of Science ®Google Scholar
• Mason D.Y., Banks P.M., Chan J., Clearly M.L., Delsol G., de Wolf P., et al. Nodular Lymphocyte Predominance Hodgkin's Disease: A distinct clinicopathological entity. American Journal of Surgical Pathology 1994; 18: 526–30
   PubMed Web of Science ®Google Scholar
• Harris N.L., Stein H., Banks P.M., et al. A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Krikorian J.G., Burke J.S., Rosenberg S.A. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. New England Journal of Medicine 1979; 300: 452–58
   PubMed Web of Science ®Google Scholar
• Armitage J.O., Dick F.R., Groeken J.A. Second lymphoid malignant neoplasm occurring in patients treated for Hodgkin's disease. Archives of Internal Medicine 1983; 14: 445–50
   Google Scholar
• Miettinen M., Fransilla K.A., Saxen E. Hodgkin's disease, Lymphocytic Predominance Nodular. Increased risk for subsequent Non-Hodgkin's Lymphomas. Cancer 1983; 51: 2293–300
   PubMed Web of Science ®Google Scholar
• Chittal S.M., Alard C., Rossi J.F., Saati T., Le Tourneau A., Diebold J., et al. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. American Journal of Surgical Pathology 1990; 14: 1024–1035
   PubMed Web of Science ®Google Scholar
• Bennet M.H., MacLennan K.A., Vaughan-Hudson G., Vaughan-Hudson B. Non-Hodgkin's lymphoma arising in patients treated for Hodgkin' s disease in the BNLI: a 20-year experience. British National Lymphoma Investigation. Annals of Oncology 1991; 2(Suppl 2)83–92
   PubMedGoogle Scholar
• Harris N.L. The relationship between Hodgkin's disease and Non-Hodgkin's Lymphoma. Seminars Diagnostic Pathology 1992; 9: 304–10
   PubMed Web of Science ®Google Scholar
• Jaffe E.S., Zarate Osorno A., Kingma D.W. The interrelationship between Hodgkin's disease and non Hodgkin's lymphomas. Annals of Oncology 1994; 5(Suppl l)S7–11
   PubMedGoogle Scholar
• Schmid C., Sangent C., Isaacson P. L and H cells of nodular lymphocyte Hodgkin's disease show immunoglobulin ligh chain restriction. American Journal of Pathology 1991; 139: 1281–89
   PubMed Web of Science ®Google Scholar
• Momose H., Chen Y.Y., Ben-Ezra J., Weiss L.M. Nodular lymphocyte-predominant Hodgkin's disease: study of immunoglobulin light chain protein and mRNA expression. Human Pathology 1992; 23: 1115–19
   PubMed Web of Science ®Google Scholar
• Kuppers R., Rajewsky K., Zhao M., Smons G., Laumann R., Fischer R., et al. Hodgkin's disease: Hodgkin and Reed Stemberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and apper to be derived from B cells at various stages of development. Proceeding of the National Academy of Science USA 1994; 91: 10962–66
   PubMed Web of Science ®Google Scholar
• Roth J., Daus H., Trumper L., et al. Detection of immunoglobulin haevy-chain gene rearrangement at the single cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Stemberg cells. International Journal of Cancer 1994; 57: 799–804
   PubMed Web of Science ®Google Scholar
• Tamaru J., Hummel M., Zemlin M., Kalvelage B., Stein H. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the Vh genes. Blood 1994; 84: 708–15
   PubMed Web of Science ®Google Scholar
• Said J.V., Sassoon A.F., Shintaku I.P., Kurtin P.J., Pinkus G. S. A. Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Souther blot analysis and polymerase chain reaction. American Journal of Pathology 1991; 138: 261–64
   PubMed Web of Science ®Google Scholar
• Delabie J., Tierens A., Wu G., Weisemburger D.D., Chan W.C. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood 1994; 84: 3291–3298
   PubMed Web of Science ®Google Scholar
• Wickert R.S., Weisenburger D.D., Tierens A., Greiner T.C., Chan W.C. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 1995; 86: 2312–2320
   PubMed Web of Science ®Google Scholar
• Stoler M.H., Nichols G.E., Symbula M., Weiss L.M. Lymphocyte predominance Hodgkin's disease. Evidence for a kappa light-chain-restricted monotypic B-cell neoplasm. American Journal of Pathology 1995; 146: 812–18
   PubMed Web of Science ®Google Scholar
• Pan L.X., Diss H.C., Peng H.Z., Norton A.J., Iasaacson P.G. Nodular lymphocyte predominance Hodgkin's disease: a monoclonal or polyclonal B-cell disorder?. Blood 1996; 87: 2428–2434
   PubMed Web of Science ®Google Scholar
• Lukes R.J., Butler J.J. The pathology and nomenclature of Hodgkin's disease. Cancer Research 1966; 26: 1063–1081
   PubMed Web of Science ®Google Scholar
• Carbone P.P., Kaplan H.S., Musshoff K. Report of the Committee on Hodgkin's disease staging. Cancer Research 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. Journal of American Statistics Association 1958; 53: 457–81
   Web of Science ®Google Scholar
• Hansmann M.L., Zwinglis T., Boske T., Loffler H., Lennert K. Clinical features of Nodular Paragranuloma (Hodgkin's disease lymphocyte predominant, nodular). Journal of Cancer Research and Clinical Oncology 1984; 108: 321–33
   PubMed Web of Science ®Google Scholar
• Regula D.P., Hoppe R.T., Weiss L.M. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. New England Journal of Medicine 1988; 318: 214–19
   PubMed Web of Science ®Google Scholar
• Trudel M.A., Krikorian J.G., Neiman R.S. Lymphocyte predominance Hodgkin's disease: A clinicopathologic reassessment. Cancer 1987; 59: 99–106
   PubMed Web of Science ®Google Scholar
• Borg-Grech A., Radford J.A., Crowther D., Swindell R., Harris M. A comparative study of nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. Journal of Clinical Oncology 1989; 7: 1303–49
   PubMed Web of Science ®Google Scholar
• Tefferi A., Zellers R.A., Banks P., Therneau T.M., Colgan J.P. Clinical Correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease. Journal of Clinical Oncology 1990; 8: 1959–1965
   PubMed Web of Science ®Google Scholar
• Papa V.I., Norton A.J., Gupatienta R.K., Wilson A.M., Rohatiner A. Z. S., Lister T.A. Nodular type of lymphocyte prdominance Hodgin's disease. A clinical study of 50 cases. Annals of Oncology 1995; 6: 559–565
   PubMed Web of Science ®Google Scholar
• Sextro M., Franklin J., Hansmann M.L., Stein H., Diehl V. Report on the consensus meeting on LP-HD (Cologne; September 1995). Annals of Oncology 1995; 7(Supplement 3)7
   Google Scholar
• Herman T., Hoppe R., Donaldson S., et al. Late relapse among patients treated for Hodgkin's disease. Annals of Internal Medicine 1985; 102: 292–97
   PubMed Web of Science ®Google Scholar
• Bodis S., Henry-Amar M., Bosq J., Burgers J. M. V., Mellink W. A. M., Dietrich P.Y., et al. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer Protocols. Journal of Clinical Oncology 1993; 11: 225–32
   PubMed Web of Science ®Google Scholar
• Poppema S., Kaiserling E., Lennert K. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centers. A cytohistological study. Histopathology 1979; 3: 295–308
   PubMed Web of Science ®Google Scholar
• Burns B.F., Colby T.V., Dorfman R.F. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. American Journal of Surgical pathology 1984; 8: 253–61
   PubMed Web of Science ®Google Scholar
• Hansmann M.L., Shibata D., Lorenzen J., Hell K., Nathwani B.N., Fischer R. Incidence of Ebstein-Barr virus bcl-2 expression and chromosomal translocation t(14; 18) in large cell lymphoma associated with paragranuloma (lymphocyte predominant Hodgkin's disease). Human Pathology 1994; 25: 240–43
   PubMed Web of Science ®Google Scholar
• Falini B., Bigema B., Pasqualucci L., et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 1996; 87: 465–471
   PubMed Web of Science ®Google Scholar
• Nolte M., Werner M., Spann W., Schnabel B., von Wasielewski R., Wilkens L., et al. The hcl-2/JH gene rearrangement is undetectable in Hodgkin's Lymphomas: results from the German Hodgkin Trial. Virchows Archives 1995; 426: 37–41
   PubMed Web of Science ®Google Scholar
• Zarate-Osorno A., Medeiros L.J., Longo D.L., Jaffe E.S. Non-Hodgkin's Lymphomas arising in patients successfully treated for Hodgkin's disease. American Journal of Surgical Pathology 1992; 16: 885–895
   PubMed Web of Science ®Google Scholar
• Dietrich P.Y., Henry-Hamar M., Cosset J.M., Bodis S., Bosq J., Hyat M. Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen?. Blood 1994; 84: 1209–1215
   PubMed Web of Science ®Google Scholar
• Van Leeuwen F.E., Klokman W.J., Hagenbeek A., Noyon R., van der Belt-Dusebout A.W., van Kerkhoff E. H. M., van Heerde P., Somers R. Second cancer risk following Hodgkin's disease: a 20-year follow up study. Journal of Clinical Oncology 1994; 12: 312–325
   PubMed Web of Science ®Google Scholar
• Hansmann M., Stein H., Fellbaum C. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Human Pathology 1989; 20: 1169–75
   PubMed Web of Science ®Google Scholar
• Paulli M., Rosso R., Kindl S., Boveri E., Sirchi M., De Medici A., Invernizzi R., Magrini U. Nodular sclerosing Hodgkin's disease and large cell lymphoma. Immunophenotypic characterization of a composite case. VirchowsArchiv A Pathological Anatomy and Histophatology 1992; 421: 271–275
   PubMed Web of Science ®Google Scholar
• Sundeen J.T., Cossman J., Jaffe E.S. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent “large cell lymphoma”: histological progression or composite malignancy?. American Journal of Surgical Pathology 1988; 12: 599–606
   PubMed Web of Science ®Google Scholar
• Grossmann D.M., Hanson C.A., Schnitzer B. Simultaneous lymphocyte predominant Hodgkin's disease and large cell lymphoma. 1991; 7(15)668–676
   Google Scholar